| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.971 | 0.004 | 0.987 | Analgesic | 0.987 0.003 DBMET00189 0.968 0.004 DBMET00190 0.936 0.004 DBMET00191 0.914 0.004 DBMET00192 0.946 0.004 DBMET01308 0.963 0.004 DBMET01309 0.983 0.003 DBMET01310 | DBMET00189 | |
| 0.876 | 0.001 | 0.876 | Hematopoietic | 0.754 0.003 DBMET00189 0.856 0.001 DBMET00190 0.856 0.001 DBMET00191 0.849 0.001 DBMET00192 0.571 0.004 DBMET01308 0.673 0.003 DBMET01309 0.675 0.003 DBMET01310 | ||
| 0.721 | 0.004 | 0.721 | Psychostimulant | 0.444 0.016 DBMET00189 0.637 0.005 DBMET00190 0.63 0.005 DBMET00191 0.606 0.006 DBMET00192 0.35 0.032 DBMET01308 0.368 0.028 DBMET01309 0.372 0.027 DBMET01310 | ||
| 0.701 | 0.004 | 0.701 | Glutamate receptor antagonist | 0.589 0.004 DBMET00189 0.579 0.004 DBMET00190 0.572 0.004 DBMET00191 0.58 0.004 DBMET00192 0.463 0.005 DBMET01308 0.453 0.005 DBMET01309 0.461 0.005 DBMET01310 | ||
| 0.694 | 0.005 | 0.694 | Anticonvulsant | 0.41 0.021 DBMET00189 0.291 0.043 DBMET00190 0.491 0.013 DBMET00191 0.428 0.019 DBMET00192 0.199 0.083 DBMET01308 0.238 0.061 DBMET01309 | ||
| 0.689 | 0.004 | 0.748 | Anesthetic general | 0.52 0.007 DBMET00189 0.64 0.004 DBMET00190 0.748 0.003 DBMET00191 0.747 0.003 DBMET00192 0.59 0.005 DBMET01308 0.591 0.005 DBMET01309 0.468 0.01 DBMET01310 | DBMET00191 | |
| 0.672 | 0.003 | 0.672 | NMDA 2B receptor antagonist | 0.385 0.004 DBMET00189 0.382 0.004 DBMET00190 0.578 0.003 DBMET00191 0.565 0.003 DBMET00192 0.28 0.004 DBMET01308 0.294 0.004 DBMET01309 0.1 0.015 DBMET01310 | ||
| 0.603 | 0.004 | 0.683 | NMDA receptor antagonist | 0.58 0.004 DBMET00189 0.683 0.003 DBMET00190 0.49 0.004 DBMET00191 0.538 0.004 DBMET00192 0.515 0.004 DBMET01308 0.467 0.004 DBMET01309 0.661 0.003 DBMET01310 | DBMET00190 | |
| 0.569 | 0.005 | 0.569 | P-glycoprotein inhibitor | 0.309 0.027 DBMET00189 0.322 0.025 DBMET00190 0.523 0.007 DBMET00191 0.513 0.008 DBMET00192 0.288 0.031 DBMET01308 0.301 0.029 DBMET01309 0.152 0.114 DBMET01310 | ||
| 0.503 | 0.003 | 0.503 | NMDA 2A receptor antagonist | 0.277 0.004 DBMET00189 0.191 0.005 DBMET00190 0.245 0.004 DBMET00191 0.188 0.005 DBMET00192 0.097 0.014 DBMET01308 0.12 0.009 DBMET01309 0.098 0.014 DBMET01310 | ||
| 0.458 | 0.003 | 0.458 | NMDA 2C receptor antagonist | 0.312 0.004 DBMET00189 0.186 0.005 DBMET00190 0.237 0.005 DBMET00191 0.2 0.005 DBMET00192 0.126 0.009 DBMET01308 0.141 0.008 DBMET01309 0.121 0.01 DBMET01310 | ||
| 0.456 | 0.003 | 0.456 | NMDA receptor subunit 3A antagonist | 0.268 0.004 DBMET00189 0.265 0.004 DBMET00190 0.357 0.003 DBMET00191 0.385 0.003 DBMET00192 0.208 0.004 DBMET01308 0.189 0.004 DBMET01309 0.139 0.005 DBMET01310 | ||
| 0.434 | 0.003 | 0.434 | NMDA receptor subunit 3B antagonist | 0.287 0.004 DBMET00189 0.255 0.004 DBMET00190 0.303 0.004 DBMET00191 0.232 0.004 DBMET00192 0.134 0.007 DBMET01308 0.179 0.005 DBMET01309 0.149 0.006 DBMET01310 | ||
| 0.404 | 0.004 | 0.404 | NMDA 2 receptor antagonist | 0.232 0.007 DBMET00189 0.257 0.006 DBMET00190 0.328 0.005 DBMET00191 0.248 0.006 DBMET00192 0.132 0.021 DBMET01308 0.184 0.011 DBMET01309 0.137 0.019 DBMET01310 | ||
| 0.464 | 0.103 | 0.854 | Antiinflammatory | 0.71 0.029 DBMET00189 0.661 0.038 DBMET00190 0.594 0.055 DBMET00191 0.756 0.021 DBMET00192 0.854 0.009 DBMET01308 0.752 0.022 DBMET01309 0.794 0.016 DBMET01310 | DBMET01308 | |
| 0.347 | 0.005 | 0.347 | Analgesic, opioid | 0.177 0.011 DBMET00189 0.171 0.012 DBMET00190 0.206 0.009 DBMET00191 0.16 0.013 DBMET00192 0.081 0.046 DBMET01308 0.108 0.027 DBMET01309 0.087 0.04 DBMET01310 | ||
| 0.37 | 0.075 | 0.473 | GABA C receptor rho-3 antagonist | 0.473 0.034 DBMET00189 0.221 0.183 DBMET00190 0.221 0.183 DBMET00191 0.221 0.183 DBMET00192 0.321 0.102 DBMET01308 0.321 0.102 DBMET01309 0.321 0.102 DBMET01310 | DBMET00189 | |
| 0.301 | 0.044 | 0.347 | 5 Hydroxytryptamine uptake stimulant | 0.347 0.026 DBMET00189 0.268 0.065 DBMET00190 0.237 0.095 DBMET00191 0.237 0.095 DBMET00192 0.272 0.062 DBMET01308 0.272 0.062 DBMET01309 0.31 0.04 DBMET01310 | DBMET00189 | |
| 0.369 | 0.131 | 0.369 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.275 0.249 DBMET00189 | ||
| 0.206 | 0.004 | 0.206 | Nociceptin (N/OFQ) receptor antagonist | 0.034 0.026 DBMET00189 0.123 0.005 DBMET00190 0.109 0.005 DBMET00191 0.046 0.017 DBMET00192 | ||
| 0.288 | 0.104 | 0.346 | Calcium channel activator | 0.315 0.078 DBMET00189 0.313 0.079 DBMET00190 0.321 0.072 DBMET00191 0.321 0.072 DBMET00192 0.346 0.052 DBMET01308 0.346 0.052 DBMET01309 0.339 0.058 DBMET01310 | DBMET01309 | |
| 0.221 | 0.058 | 0.285 | Neurotrophic factor enhancer | 0.228 0.053 DBMET00189 0.229 0.052 DBMET00190 0.249 0.039 DBMET00191 0.278 0.025 DBMET00192 0.285 0.023 DBMET01308 0.256 0.035 DBMET01309 0.236 0.047 DBMET01310 | DBMET01308 | |
| 0.246 | 0.091 | 0.373 | 5 Hydroxytryptamine release stimulant | 0.373 0.051 DBMET00189 0.241 0.094 DBMET00190 0.241 0.094 DBMET00191 0.241 0.094 DBMET00192 0.365 0.053 DBMET01308 0.365 0.053 DBMET01309 0.365 0.053 DBMET01310 | DBMET00189 | |
| 0.22 | 0.073 | 0.289 | RNA-directed DNA polymerase inhibitor | 0.25 0.05 DBMET00189 0.224 0.069 DBMET00190 0.218 0.076 DBMET00191 0.249 0.05 DBMET00192 0.289 0.034 DBMET01308 0.247 0.051 DBMET01309 0.254 0.047 DBMET01310 | DBMET01308 | |
| 0.26 | 0.118 | 0.485 | Cholesterol antagonist | 0.287 0.1 DBMET00189 0.322 0.078 DBMET00190 0.352 0.063 DBMET00191 0.438 0.042 DBMET00192 0.485 0.035 DBMET01308 0.386 0.053 DBMET01309 0.347 0.065 DBMET01310 | DBMET01308 | |
| 0.235 | 0.098 | 0.235 | Gastrin inhibitor | 0.196 0.155 DBMET00190 0.218 0.123 DBMET00191 0.212 0.132 DBMET00192 | ||
| 0.176 | 0.041 | 0.176 | Calcium channel blocker | |||
| 0.18 | 0.054 | 0.218 | Arachidonic acid antagonist | 0.198 0.035 DBMET00189 0.194 0.039 DBMET00190 0.188 0.045 DBMET00191 0.203 0.03 DBMET00192 0.218 0.018 DBMET01308 0.205 0.029 DBMET01309 0.21 0.024 DBMET01310 | DBMET01308 | |
| 0.126 | 0.002 | 0.126 | NMDA receptor phencyclidine site antagonist | 0.057 0.003 DBMET00189 0.047 0.003 DBMET00190 0.062 0.003 DBMET00191 0.082 0.002 DBMET00192 0.04 0.004 DBMET01308 0.032 0.004 DBMET01309 0.024 0.005 DBMET01310 | ||
| 0.224 | 0.099 | 0.384 | Interleukin agonist | 0.282 0.058 DBMET00189 0.238 0.088 DBMET00190 0.322 0.038 DBMET00191 0.263 0.07 DBMET00192 0.32 0.039 DBMET01308 0.384 0.021 DBMET01309 0.295 0.05 DBMET01310 | DBMET01309 | |
| 0.221 | 0.101 | 0.264 | Tyrosine 3 hydroxylase inhibitor | 0.264 0.055 DBMET00189 0.18 0.175 DBMET00190 0.18 0.175 DBMET00191 0.18 0.175 DBMET00192 0.218 0.106 DBMET01308 0.218 0.106 DBMET01309 0.218 0.106 DBMET01310 | DBMET00189 | |
| 0.13 | 0.014 | 0.13 | Calcium channel L-type blocker | 0.067 0.057 DBMET00189 0.08 0.039 DBMET00191 0.065 0.059 DBMET00192 | ||
| 0.157 | 0.041 | 0.17 | Pregnane X receptor agonist | 0.149 0.054 DBMET00189 0.152 0.049 DBMET00190 0.154 0.046 DBMET00191 0.17 0.026 DBMET00192 0.162 0.035 DBMET01308 0.146 0.06 DBMET01309 0.144 0.064 DBMET01310 | DBMET00192 | |
| 0.274 | 0.162 | 0.281 | MAP kinase kinase 6 inhibitor | 0.281 0.154 DBMET00190 0.254 0.185 DBMET00191 0.254 0.185 DBMET00192 | DBMET00190 | |
| 0.146 | 0.035 | 0.146 | Calcium channel (voltage-sensitive) blocker | |||
| 0.189 | 0.083 | 0.189 | 5 Hydroxytryptamine 3E antagonist | 0.183 0.097 DBMET00189 | ||
| 0.286 | 0.181 | 0.308 | 5 Hydroxytryptamine release inhibitor | 0.308 0.156 DBMET00189 0.259 0.215 DBMET01308 0.259 0.215 DBMET01309 0.259 0.215 DBMET01310 | DBMET00189 | |
| 0.136 | 0.031 | 0.192 | Creatine kinase inhibitor | 0.186 0.013 DBMET00189 0.126 0.036 DBMET00190 0.113 0.047 DBMET00191 0.141 0.028 DBMET00192 0.192 0.012 DBMET01308 0.158 0.021 DBMET01309 0.174 0.016 DBMET01310 | DBMET01308 | |
| 0.112 | 0.011 | 0.112 | Antidiuretic hormone antagonist | 0.072 0.017 DBMET00189 0.048 0.023 DBMET00190 0.038 0.029 DBMET00191 0.04 0.027 DBMET00192 | ||
| 0.11 | 0.02 | 0.451 | Protein kinase B beta inhibitor | 0.451 0.003 DBMET00189 0.076 0.047 DBMET00190 0.071 0.055 DBMET00191 0.257 0.004 DBMET01308 0.358 0.003 DBMET01309 0.364 0.003 DBMET01310 | DBMET00189 | |
| 0.097 | 0.009 | 0.097 | Potassium channel intermediate-conductance Ca-activated blocker | 0.092 0.011 DBMET00189 | ||
| 0.205 | 0.125 | 0.205 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.09 | 0.015 | 0.09 | Opioid agonist | 0.05 0.04 DBMET00189 0.057 0.032 DBMET00190 0.06 0.03 DBMET00191 0.057 0.032 DBMET00192 | ||
| 0.153 | 0.083 | 0.176 | Sigma receptor agonist | 0.135 0.097 DBMET00189 0.176 0.071 DBMET00190 0.126 0.107 DBMET00191 0.126 0.107 DBMET00192 0.16 0.079 DBMET01310 | DBMET00190 | |
| 0.109 | 0.042 | 0.109 | Opioid antagonist | 0.094 0.053 DBMET00190 0.076 0.075 DBMET00191 | ||
| 0.103 | 0.038 | 0.163 | Glutamate release inhibitor | 0.163 0.007 DBMET00189 0.096 0.05 DBMET00190 0.092 0.058 DBMET00191 0.092 0.058 DBMET00192 0.141 0.012 DBMET01308 0.141 0.012 DBMET01309 0.149 0.01 DBMET01310 | DBMET00189 | |
| 0.087 | 0.024 | 0.087 | NMDA receptor glycine site agonist | 0.077 0.03 DBMET00189 | ||
| 0.074 | 0.01 | 0.074 | Potassium channel (Inward rectifier) activator | 0.064 0.016 DBMET00189 0.059 0.021 DBMET00190 0.051 0.035 DBMET00191 0.052 0.032 DBMET00192 0.051 0.033 DBMET01310 | ||
| 0.185 | 0.121 | 0.292 | Peptidyltransferase inhibitor | 0.269 0.038 DBMET00190 0.292 0.028 DBMET00191 0.292 0.028 DBMET00192 0.276 0.035 DBMET01308 0.276 0.035 DBMET01309 0.249 0.051 DBMET01310 | DBMET00192 | |
| 0.096 | 0.033 | 0.096 | Opioid mu receptor antagonist | 0.063 0.051 DBMET00190 | ||
| 0.157 | 0.095 | 0.264 | Lipocortins synthesis antagonist | 0.183 0.068 DBMET00189 0.175 0.076 DBMET00190 0.175 0.076 DBMET00191 0.238 0.038 DBMET00192 0.264 0.029 DBMET01308 0.198 0.058 DBMET01309 0.198 0.058 DBMET01310 | DBMET01308 | |
| 0.07 | 0.01 | 0.07 | Potassium channel (ATP-sensitive) activator | 0.061 0.015 DBMET00189 0.056 0.02 DBMET00190 0.048 0.033 DBMET00191 0.049 0.031 DBMET00192 0.049 0.032 DBMET01310 | ||
| 0.077 | 0.018 | 0.077 | Dopamine transporter inhibitor | 0.066 0.022 DBMET00190 0.059 0.025 DBMET00191 | ||
| 0.142 | 0.085 | 0.16 | GABA C receptor rho-2 antagonist | 0.16 0.061 DBMET00189 | DBMET00189 | |
| 0.176 | 0.119 | 0.335 | Aldehyde oxidase inhibitor | 0.226 0.092 DBMET00189 0.262 0.078 DBMET00190 0.237 0.087 DBMET00191 0.237 0.087 DBMET00192 0.302 0.066 DBMET01308 0.302 0.066 DBMET01309 0.335 0.058 DBMET01310 | DBMET01310 | |
| 0.156 | 0.101 | 0.193 | Succinate dehydrogenase inhibitor | 0.193 0.055 DBMET00189 0.168 0.083 DBMET01308 0.168 0.083 DBMET01309 0.168 0.083 DBMET01310 | DBMET00189 | |
| 0.078 | 0.026 | 0.078 | Dopamine uptake inhibitor | 0.073 0.028 DBMET00190 0.066 0.033 DBMET00191 | ||
| 0.193 | 0.144 | 0.193 | MAP kinase kinase 3 inhibitor | |||
| 0.136 | 0.091 | 0.16 | Ca2+-transporting ATPase inhibitor | 0.15 0.042 DBMET00189 0.145 0.058 DBMET00190 0.145 0.058 DBMET00191 0.145 0.058 DBMET00192 0.16 0.024 DBMET01308 0.16 0.024 DBMET01309 0.16 0.024 DBMET01310 | DBMET01310 | |
| 0.075 | 0.032 | 0.075 | NMDA receptor agonist | 0.071 0.035 DBMET00189 | ||
| 0.139 | 0.097 | 0.163 | CF transmembrane conductance regulator agonist | 0.163 0.055 DBMET00190 0.154 0.069 DBMET00191 0.154 0.069 DBMET00192 0.139 0.096 DBMET01308 0.139 0.096 DBMET01309 0.148 0.079 DBMET01310 | DBMET00190 | |
| 0.176 | 0.138 | 0.222 | Nitric-oxide synthase stimulant | 0.212 0.07 DBMET00189 0.185 0.118 DBMET00190 0.185 0.118 DBMET00191 0.185 0.118 DBMET00192 0.222 0.058 DBMET01308 0.222 0.058 DBMET01309 0.222 0.058 DBMET01310 | DBMET01310 | |
| 0.084 | 0.051 | 0.152 | T cell inhibitor | 0.086 0.047 DBMET00190 0.152 0.01 DBMET00191 0.09 0.038 DBMET00192 0.123 0.014 DBMET01309 | DBMET00191 | |
| 0.125 | 0.093 | 0.128 | CC chemokine 6 receptor antagonist | 0.128 0.079 DBMET00190 0.124 0.097 DBMET00191 0.124 0.097 DBMET00192 0.12 0.118 DBMET01310 | DBMET00190 | |
| 0.103 | 0.072 | 0.142 | 5 Hydroxytryptamine 3A agonist | 0.142 0.04 DBMET00189 | DBMET00189 | |
| 0.115 | 0.083 | 0.115 | Sphingosine 1-phosphate receptor 4 antagonist | 0.112 0.088 DBMET00189 | ||
| 0.09 | 0.06 | 0.09 | Potassium channel activator | |||
| 0.097 | 0.067 | 0.111 | GABA C receptor rho-1 antagonist | 0.111 0.049 DBMET00189 | DBMET00189 | |
| 0.033 | 0.004 | 0.036 | Somatostatin 3 agonist | 0.036 0.004 DBMET00189 0.024 0.006 DBMET00190 0.022 0.008 DBMET00191 0.022 0.008 DBMET01309 0.025 0.005 DBMET01310 | DBMET00189 | |
| 0.082 | 0.053 | 0.119 | Glycine receptor antagonist | 0.089 0.044 DBMET00189 0.1 0.033 DBMET00190 0.095 0.037 DBMET00191 0.113 0.023 DBMET00192 0.119 0.018 DBMET01308 0.102 0.03 DBMET01309 0.107 0.027 DBMET01310 | DBMET01308 | |
| 0.083 | 0.054 | 0.083 | Opioid kappa receptor antagonist | 0.078 0.061 DBMET00190 | ||
| 0.096 | 0.068 | 0.152 | Anabolic | 0.112 0.047 DBMET00189 0.118 0.042 DBMET00190 0.124 0.036 DBMET00191 0.139 0.025 DBMET00192 0.152 0.017 DBMET01308 0.139 0.024 DBMET01309 0.133 0.028 DBMET01310 | DBMET01308 | |
| 0.041 | 0.013 | 0.041 | Histamine H3 receptor agonist | |||
| 0.108 | 0.08 | 0.124 | Interleukin 8 antagonist | 0.1 0.096 DBMET00191 0.124 0.057 DBMET00192 0.112 0.073 DBMET01308 | DBMET00192 | |
| 0.058 | 0.037 | 0.064 | Pregnane X receptor antagonist | 0.063 0.025 DBMET00189 0.059 0.034 DBMET00192 0.064 0.023 DBMET01308 0.055 0.045 DBMET01309 | DBMET01308 | |
| 0.092 | 0.071 | 0.15 | UDP-glucose 4-epimerase inhibitor | 0.125 0.04 DBMET00189 0.102 0.059 DBMET00190 0.088 0.076 DBMET00191 0.11 0.051 DBMET00192 0.15 0.029 DBMET01308 0.121 0.043 DBMET01309 0.139 0.033 DBMET01310 | DBMET01308 | |
| 0.031 | 0.016 | 0.047 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.036 0.013 DBMET00189 0.04 0.011 DBMET00190 0.033 0.015 DBMET00192 0.038 0.012 DBMET01308 0.028 0.019 DBMET01309 0.047 0.009 DBMET01310 | DBMET01310 | |
| 0.052 | 0.038 | 0.052 | Nicotinic alpha3beta2 receptor antagonist | 0.052 0.039 DBMET00190 0.05 0.043 DBMET00191 0.05 0.043 DBMET00192 | ||
| 0.029 | 0.015 | 0.042 | Hedgehog signaling activator | 0.038 0.005 DBMET00190 0.042 0.004 DBMET00191 0.042 0.004 DBMET00192 0.034 0.007 DBMET01308 0.034 0.007 DBMET01309 0.032 0.01 DBMET01310 | DBMET00192 | |
| 0.017 | 0.004 | 0.018 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.018 0.004 DBMET00189 0.012 0.008 DBMET00192 0.012 0.008 DBMET01308 | DBMET00189 | |
| 0.027 | 0.014 | 0.027 | NMDA receptor glycine site antagonist | |||
| 0.033 | 0.021 | 0.042 | Somatostatin agonist | 0.042 0.016 DBMET00189 | DBMET00189 | |
| 0.072 | 0.06 | 0.072 | Vanilloid 4 agonist | |||
| 0.095 | 0.086 | 0.118 | GABA C receptor antagonist | 0.118 0.054 DBMET00189 | DBMET00189 | |
| 0.123 | 0.117 | 0.175 | Adenylate cyclase stimulant | 0.132 0.097 DBMET00189 0.167 0.039 DBMET00190 0.158 0.051 DBMET00191 0.158 0.051 DBMET00192 0.165 0.041 DBMET01308 0.165 0.041 DBMET01309 0.175 0.031 DBMET01310 | DBMET01310 | |
| 0.063 | 0.057 | 0.372 | Protein kinase B alpha inhibitor | 0.372 0.003 DBMET00189 0.16 0.007 DBMET01308 0.238 0.004 DBMET01309 0.25 0.004 DBMET01310 | DBMET00189 | |
| 0.063 | 0.058 | 0.101 | Glutamate (mGluR6) antagonist | 0.097 0.012 DBMET00189 0.065 0.051 DBMET00190 0.065 0.051 DBMET00191 0.065 0.051 DBMET00192 0.101 0.01 DBMET01308 0.101 0.01 DBMET01309 0.101 0.01 DBMET01310 | DBMET01310 | |
| 0.051 | 0.047 | 0.052 | Dihydroorotate oxidase inhibitor | 0.052 0.045 DBMET00189 | DBMET00189 | |
| 0.068 | 0.065 | 0.097 | GABA aminotransferase inhibitor | 0.097 0.029 DBMET00189 0.081 0.045 DBMET01308 0.081 0.045 DBMET01309 0.087 0.039 DBMET01310 | DBMET00189 | |
| 0.04 | 0.037 | 0.04 | Nerve growth factor antagonist | |||
| 0.09 | 0.089 | 0.14 | Cystathionine beta-synthase inhibitor | 0.132 0.05 DBMET00189 0.095 0.082 DBMET00190 0.095 0.082 DBMET00191 0.095 0.082 DBMET00192 0.14 0.046 DBMET01308 0.14 0.046 DBMET01309 0.14 0.046 DBMET01310 | DBMET01310 | |
| 0.113 | 0.114 | 0.123 | Mannose-6-phosphate isomerase inhibitor | 0.123 0.096 DBMET00189 0.118 0.104 DBMET01308 0.118 0.104 DBMET01309 0.123 0.096 DBMET01310 | DBMET01310 | |
| 0.048 | 0.05 | 0.067 | Nicotinic receptor alpha7 subunit antagonist | 0.067 0.023 DBMET00189 0.057 0.032 DBMET01310 | DBMET00189 | |
| 0.014 | 0.015 | 0.014 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.014 0.012 DBMET00189 | DBMET00189 | |
| 0.077 | 0.079 | 0.086 | D-Ala-D-Ala ligase inhibitor | 0.086 0.053 DBMET00189 | DBMET00189 | |
| 0.088 | 0.091 | 0.091 | Glutamate (mGluR7) agonist | 0.091 0.082 DBMET00191 0.091 0.082 DBMET00192 | DBMET00192 | |
| 0.226 | 0.233 | 0.231 | Calcium channel L-type activator | 0.231 0.228 DBMET00190 | DBMET00190 | |
| 0.09 | 0.098 | 0.139 | DOPA decarboxylase inhibitor | 0.139 0.028 DBMET00189 0.113 0.054 DBMET01308 0.113 0.054 DBMET01309 0.118 0.047 DBMET01310 | DBMET00189 | |
| 0.038 | 0.047 | 0.072 | Adenylate cyclase 1 inhibitor | 0.069 0.013 DBMET00190 0.052 0.025 DBMET00191 0.052 0.025 DBMET00192 0.055 0.021 DBMET01308 0.055 0.021 DBMET01309 0.072 0.011 DBMET01310 | DBMET01310 | |
| 0.122 | 0.13 | 0.213 | Interferon gamma antagonist | 0.144 0.086 DBMET00189 0.141 0.091 DBMET00190 0.172 0.055 DBMET00191 0.167 0.059 DBMET00192 0.204 0.039 DBMET01308 0.213 0.037 DBMET01309 0.167 0.06 DBMET01310 | DBMET01309 | |
| 0.054 | 0.064 | 0.057 | Corticotropin releasing factor 2 receptor antagonist | 0.057 0.053 DBMET00189 | DBMET00189 | |
| 0.067 | 0.078 | 0.08 | Carbonic anhydrase VI inhibitor | 0.077 0.061 DBMET00189 0.08 0.057 DBMET01308 0.071 0.07 DBMET01310 | DBMET01308 | |
| 0.013 | 0.025 | 0.015 | Antibiotic Tetracycline-like | 0.015 0.012 DBMET00190 0.015 0.012 DBMET00191 0.015 0.012 DBMET00192 | DBMET00192 | |
| 0.035 | 0.048 | 0.042 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.042 0.028 DBMET00189 | DBMET00189 | |
| 0.057 | 0.075 | 0.067 | Calcium channel P-type blocker | 0.067 0.036 DBMET00189 0.063 0.046 DBMET01308 0.063 0.046 DBMET01310 | DBMET00189 | |
| 0.016 | 0.035 | 0.022 | Protein 30S ribosomal subunit inhibitor | 0.022 0.019 DBMET00190 0.021 0.02 DBMET00191 0.022 0.019 DBMET00192 | DBMET00192 | |
| 0.105 | 0.125 | 0.137 | Diuretic | 0.137 0.088 DBMET00189 | DBMET00189 | |
| 0.061 | 0.084 | 0.106 | Acetylcholine nicotinic antagonist | 0.106 0.036 DBMET00189 0.105 0.036 DBMET01310 | DBMET00189 | |
| 0.144 | 0.167 | 0.208 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.164 0.118 DBMET00189 0.176 0.098 DBMET00190 0.159 0.129 DBMET00191 0.177 0.098 DBMET00192 0.208 0.066 DBMET01308 0.183 0.089 DBMET01309 0.208 0.066 DBMET01310 | DBMET01310 | |
| 0.015 | 0.04 | 0.06 | RNA-directed RNA polymerase stimulant | 0.025 0.024 DBMET00190 0.032 0.02 DBMET00191 0.05 0.013 DBMET00192 0.06 0.011 DBMET01308 0.038 0.017 DBMET01309 0.03 0.021 DBMET01310 | DBMET01308 | |
| 0.026 | 0.052 | 0.071 | Glutamate (mGluR3) antagonist | 0.045 0.016 DBMET00189 0.035 0.028 DBMET00191 0.04 0.021 DBMET00192 0.071 0.006 DBMET01308 0.061 0.008 DBMET01309 0.053 0.011 DBMET01310 | DBMET01308 | |
| 0.009 | 0.04 | 0.017 | Thromboxane A2 agonist | 0.015 0.012 DBMET00190 0.016 0.01 DBMET00191 0.017 0.008 DBMET01309 0.016 0.01 DBMET01310 | DBMET01309 | |
| 0.042 | 0.074 | 0.087 | Androgen agonist | 0.075 0.027 DBMET00190 0.064 0.036 DBMET00191 0.087 0.02 DBMET00192 0.086 0.021 DBMET01308 0.064 0.037 DBMET01309 0.074 0.027 DBMET01310 | DBMET00192 | |
| 0.07 | 0.106 | 0.08 | Bromodomain-containing protein 2 inhibitor | 0.08 0.076 DBMET00189 | DBMET00189 | |
| 0.014 | 0.052 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.016 DBMET00192 0.022 0.012 DBMET01308 | DBMET01308 | |
| 0.012 | 0.053 | 0.019 | Antibiotic Anthracycline-like | 0.019 0.014 DBMET01308 | DBMET01308 | |
| 0.073 | 0.116 | 0.101 | Electrolyte absorption antagonist | 0.101 0.056 DBMET00189 | DBMET00189 | |
| 0.084 | 0.128 | 0.138 | Alpha-N-acetylglucosaminidase inhibitor | 0.13 0.069 DBMET00190 0.13 0.069 DBMET00191 0.13 0.069 DBMET00192 0.138 0.062 DBMET01308 0.138 0.062 DBMET01309 0.138 0.062 DBMET01310 | DBMET01310 | |
| 0.024 | 0.068 | 0.043 | Dopamine D5 agonist | 0.043 0.024 DBMET00189 | DBMET00189 | |
| 0.044 | 0.088 | 0.071 | Prostaglandin F2 alpha antagonist | 0.071 0.031 DBMET00190 0.066 0.037 DBMET00191 0.062 0.043 DBMET01309 0.067 0.035 DBMET01310 | DBMET00190 | |
| 0.044 | 0.088 | 0.085 | Neuronal nicotinic receptor antagonist | 0.085 0.032 DBMET00189 0.075 0.041 DBMET01310 | DBMET00189 | |
| 0.023 | 0.071 | 0.042 | Ceramide glucosyltransferase inhibitor | 0.038 0.021 DBMET00190 0.042 0.015 DBMET00191 0.042 0.015 DBMET00192 0.042 0.014 DBMET01308 0.042 0.014 DBMET01309 0.038 0.02 DBMET01310 | DBMET01309 | |
| 0.069 | 0.118 | 0.139 | GABA C receptor agonist | 0.139 0.039 DBMET00189 0.105 0.062 DBMET01308 0.105 0.062 DBMET01309 0.105 0.062 DBMET01310 | DBMET00189 | |
| 0.066 | 0.116 | 0.102 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.092 0.063 DBMET00189 0.102 0.052 DBMET01308 0.102 0.052 DBMET01309 0.102 0.052 DBMET01310 | DBMET01310 | |
| 0.056 | 0.106 | 0.075 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.075 0.047 DBMET00189 0.071 0.056 DBMET01310 | DBMET00189 | |
| 0.06 | 0.111 | 0.085 | GABA B receptor agonist | 0.079 0.044 DBMET00189 0.085 0.032 DBMET01308 0.085 0.032 DBMET01309 0.077 0.047 DBMET01310 | DBMET01309 | |
| 0.123 | 0.176 | 0.218 | Phospholipase C inhibitor | 0.147 0.112 DBMET00189 0.151 0.103 DBMET00190 0.164 0.081 DBMET00191 0.18 0.06 DBMET00192 0.218 0.034 DBMET01308 0.195 0.047 DBMET01309 0.179 0.062 DBMET01310 | DBMET01308 | |
| 0.046 | 0.1 | 0.064 | Lipocortins synthesis agonist | 0.055 0.048 DBMET00190 0.054 0.051 DBMET00191 0.06 0.035 DBMET00192 0.064 0.029 DBMET01308 0.057 0.042 DBMET01309 0.058 0.04 DBMET01310 | DBMET01308 | |
| 0.017 | 0.074 | 0.032 | Purinergic P2Y15 antagonist | 0.03 0.017 DBMET01308 0.03 0.017 DBMET01309 0.032 0.014 DBMET01310 | DBMET01310 | |
| 0.108 | 0.166 | 0.126 | Sphingosine 1-phosphate receptor 5 antagonist | 0.126 0.11 DBMET00189 | DBMET00189 | |
| 0.06 | 0.12 | 0.134 | HIV-1 integrase (Overall Integration) inhibitor | 0.121 0.039 DBMET00189 0.116 0.042 DBMET01308 0.116 0.042 DBMET01309 0.134 0.032 DBMET01310 | DBMET01310 | |
| 0.023 | 0.086 | 0.035 | Antibiotic Aminoglycoside-like | 0.035 0.027 DBMET00190 0.035 0.027 DBMET00191 0.035 0.027 DBMET00192 | DBMET00192 | |
| 0.02 | 0.084 | 0.04 | Opioid kappa receptor agonist | 0.04 0.034 DBMET01310 | DBMET01310 | |
| 0.03 | 0.094 | 0.069 | Argininosuccinate synthase inhibitor | 0.064 0.034 DBMET00189 0.069 0.03 DBMET01308 0.052 0.045 DBMET01309 0.064 0.034 DBMET01310 | DBMET01308 | |
| 0.057 | 0.122 | 0.072 | Estrogen receptor alpha antagonist | 0.072 0.064 DBMET01308 | DBMET01308 | |
| 0.223 | 0.288 | 0.397 | Caspase 9 stimulant | 0.291 0.204 DBMET00190 0.366 0.133 DBMET00191 0.29 0.204 DBMET00192 0.315 0.177 DBMET01308 0.397 0.113 DBMET01309 0.316 0.177 DBMET01310 | DBMET01309 | |
| 0.061 | 0.127 | 0.077 | MAP kinase kinase 7 inhibitor | 0.073 0.071 DBMET00190 0.075 0.063 DBMET00191 0.075 0.063 DBMET00192 0.077 0.056 DBMET01308 0.077 0.056 DBMET01309 0.075 0.063 DBMET01310 | DBMET01309 | |
| 0.032 | 0.1 | 0.051 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.051 0.041 DBMET01308 | DBMET01308 | |
| 0.063 | 0.133 | 0.105 | Interleukin 5 antagonist | 0.098 0.044 DBMET00191 0.105 0.036 DBMET01309 | DBMET01309 | |
| 0.078 | 0.149 | 0.12 | Cyclooxygenase 3 inhibitor | 0.12 0.077 DBMET01308 | DBMET01308 | |
| 0.038 | 0.112 | 0.057 | Purinergic P2X1 antagonist | 0.055 0.051 DBMET01308 0.055 0.051 DBMET01309 0.057 0.048 DBMET01310 | DBMET01310 | |
| 0.061 | 0.136 | 0.122 | NADH dehydrogenase inhibitor | 0.096 0.048 DBMET00189 0.122 0.027 DBMET01308 0.122 0.027 DBMET01309 0.122 0.027 DBMET01310 | DBMET01310 | |
| 0.039 | 0.116 | 0.092 | Na+ K+ transporting ATPase inhibitor | 0.08 0.05 DBMET00192 0.092 0.039 DBMET01308 0.079 0.052 DBMET01309 0.073 0.057 DBMET01310 | DBMET01308 | |
| 0.024 | 0.101 | 0.036 | Glutamate (mGluR8) agonist | 0.036 0.03 DBMET00189 | DBMET00189 | |
| 0.08 | 0.159 | 0.103 | Cathepsin H inhibitor | 0.103 0.101 DBMET00189 | DBMET00189 | |
| 0.032 | 0.111 | 0.08 | Phosphofructokinase-1 inhibitor | 0.08 0.041 DBMET01308 0.08 0.041 DBMET01309 0.08 0.041 DBMET01310 | DBMET01310 | |
| 0.027 | 0.107 | 0.183 | Alcohol oxidase inhibitor | 0.053 0.042 DBMET00189 0.052 0.044 DBMET00191 0.075 0.026 DBMET00192 0.183 0.007 DBMET01308 0.122 0.014 DBMET01309 0.08 0.024 DBMET01310 | DBMET01308 | |
| 0.01 | 0.091 | 0.025 | Sodium/glucose cotransporter 2 inhibitor | 0.025 0.022 DBMET01308 | DBMET01308 | |
| 0.063 | 0.148 | 0.102 | Bile acid receptor antagonist | 0.093 0.067 DBMET00191 0.1 0.049 DBMET00192 0.102 0.046 DBMET01308 0.094 0.063 DBMET01309 | DBMET01308 | |
| 0.066 | 0.153 | 0.092 | Carbonic anhydrase XV inhibitor | 0.092 0.079 DBMET00189 | DBMET00189 | |
| 0.044 | 0.132 | 0.064 | Secretase beta inhibitor | 0.064 0.062 DBMET00189 | DBMET00189 | |
| 0.063 | 0.152 | 0.154 | Cholesterol synthesis inhibitor | 0.138 0.051 DBMET00191 0.13 0.057 DBMET00192 0.145 0.047 DBMET01308 0.154 0.043 DBMET01309 0.103 0.083 DBMET01310 | DBMET01309 | |
| 0.025 | 0.114 | 0.047 | Glucose-6-phosphate dehydrogenase inhibitor | 0.036 0.031 DBMET00191 0.044 0.017 DBMET00192 0.047 0.014 DBMET01308 0.038 0.025 DBMET01309 | DBMET01308 | |
| 0.166 | 0.257 | 0.408 | Interleukin 2 agonist | 0.228 0.145 DBMET00189 0.235 0.136 DBMET00190 0.366 0.039 DBMET00191 0.328 0.056 DBMET00192 0.372 0.037 DBMET01308 0.408 0.025 DBMET01309 0.284 0.086 DBMET01310 | DBMET01309 | |
| 0.025 | 0.117 | 0.036 | Vanilloid 3 antagonist | 0.036 0.035 DBMET01308 | DBMET01308 | |
| 0.068 | 0.16 | 0.114 | Toll-Like receptor 4 antagonist | 0.1 0.07 DBMET00192 0.114 0.05 DBMET01308 | DBMET01308 | |
| 0.131 | 0.223 | 0.21 | Superoxide dismutase inhibitor | 0.201 0.116 DBMET00189 0.182 0.139 DBMET01308 0.182 0.139 DBMET01309 0.21 0.107 DBMET01310 | DBMET01310 | |
| 0.06 | 0.153 | 0.137 | Lanosterol 14 alpha demethylase inhibitor | 0.088 0.075 DBMET00189 0.085 0.08 DBMET00190 0.109 0.044 DBMET00191 0.109 0.044 DBMET00192 0.137 0.017 DBMET01308 0.137 0.017 DBMET01309 0.116 0.034 DBMET01310 | DBMET01309 | |
| 0.042 | 0.14 | 0.086 | Androgen antagonist | 0.086 0.059 DBMET00192 | DBMET00192 | |
| 0.036 | 0.137 | 0.069 | Heat shock protein 90 beta antagonist | 0.069 0.029 DBMET01308 0.058 0.043 DBMET01309 | DBMET01308 | |
| 0.027 | 0.129 | 0.083 | Carbamoyl phosphate synthetase inhibitor | 0.059 0.044 DBMET00189 0.083 0.027 DBMET01308 0.083 0.027 DBMET01309 0.083 0.027 DBMET01310 | DBMET01310 | |
| 0.033 | 0.135 | 0.066 | Histidine decarboxylase inhibitor | 0.066 0.055 DBMET01308 0.066 0.055 DBMET01309 0.066 0.055 DBMET01310 | DBMET01310 | |
| 0.042 | 0.145 | 0.074 | Glutamate dehydrogenase inhibitor | 0.074 0.052 DBMET01308 0.074 0.052 DBMET01309 0.074 0.052 DBMET01310 | DBMET01310 | |
| 0.059 | 0.164 | 0.139 | Adenylate cyclase inhibitor | 0.108 0.078 DBMET00190 0.139 0.052 DBMET00191 0.116 0.071 DBMET00192 0.114 0.072 DBMET01308 0.138 0.053 DBMET01309 0.106 0.079 DBMET01310 | DBMET00191 | |
| 0.108 | 0.212 | 0.162 | ATPase inhibitor | 0.139 0.121 DBMET00190 0.153 0.096 DBMET00191 0.162 0.082 DBMET00192 0.162 0.082 DBMET01308 0.153 0.097 DBMET01309 0.139 0.121 DBMET01310 | DBMET01308 | |
| 0.004 | 0.11 | 0.032 | Estrogen receptor alpha agonist | 0.032 0.025 DBMET01308 | DBMET01308 | |
| 0.03 | 0.136 | 0.044 | Parathyroid hormone antagonist | 0.044 0.035 DBMET00191 0.044 0.035 DBMET00192 0.042 0.041 DBMET01308 0.042 0.041 DBMET01309 | DBMET00192 | |
| 0.012 | 0.119 | 0.033 | Farnesoid X receptor agonist | 0.033 0.032 DBMET00192 | DBMET00192 | |
| 0.009 | 0.116 | 0.022 | Isoleucine-tRNA ligase inhibitor | 0.022 0.016 DBMET01308 0.022 0.016 DBMET01309 0.022 0.016 DBMET01310 | DBMET01310 | |
| 0.071 | 0.182 | 0.116 | Acetylcholine release stimulant | 0.116 0.055 DBMET00189 | DBMET00189 | |
| 0.075 | 0.186 | 0.147 | Peroxidase inhibitor | 0.147 0.08 DBMET00189 0.121 0.099 DBMET01308 0.121 0.099 DBMET01309 0.121 0.099 DBMET01310 | DBMET00189 | |
| 0.04 | 0.154 | 0.087 | Protein kinase B gamma inhibitor | 0.087 0.041 DBMET00189 | DBMET00189 | |
| 0.021 | 0.14 | 0.033 | Glutamate (mGluR8) antagonist | 0.033 0.031 DBMET00189 0.033 0.031 DBMET01310 | DBMET01310 | |
| 0.084 | 0.203 | 0.146 | Hexokinase inhibitor | 0.146 0.083 DBMET01308 | DBMET01308 | |
| 0.022 | 0.141 | 0.038 | Thymidine kinase inhibitor | 0.038 0.033 DBMET01308 | DBMET01308 | |
| 0.052 | 0.173 | 0.085 | Triose-phosphate isomerase inhibitor | 0.085 0.068 DBMET01308 0.085 0.068 DBMET01309 0.085 0.068 DBMET01310 | DBMET01310 | |
| 0.055 | 0.179 | 0.103 | Estrogen receptor beta antagonist | 0.096 0.072 DBMET00192 0.103 0.059 DBMET01308 | DBMET01308 | |
| 0.091 | 0.217 | 0.14 | Melanin inhibitor | 0.14 0.096 DBMET01308 0.127 0.119 DBMET01310 | DBMET01308 | |
| 0.128 | 0.257 | 0.309 | DNA synthesis inhibitor | 0.192 0.136 DBMET00189 0.188 0.141 DBMET00190 0.233 0.079 DBMET00191 0.212 0.106 DBMET00192 0.276 0.053 DBMET01308 0.309 0.041 DBMET01309 0.245 0.069 DBMET01310 | DBMET01309 | |
| 0.066 | 0.195 | 0.103 | Aldehyde dehydrogenase inhibitor | 0.103 0.093 DBMET01308 | DBMET01308 | |
| 0.023 | 0.162 | 0.049 | Alpha-mannosidase inhibitor | 0.049 0.045 DBMET01310 | DBMET01310 | |
| 0.025 | 0.183 | 0.063 | Sphingosine kinase 2 inhibitor | 0.063 0.028 DBMET01308 0.063 0.028 DBMET01309 0.056 0.037 DBMET01310 | DBMET01309 | |
| 0.052 | 0.212 | 0.082 | Granulocyte macrophage colony stimulating factor agonist | 0.082 0.071 DBMET00189 | DBMET00189 | |
| 0.061 | 0.222 | 0.113 | Estrogen antagonist | 0.108 0.08 DBMET00192 0.113 0.069 DBMET01308 | DBMET01308 | |
| 0.05 | 0.219 | 0.135 | Acetylcholine antagonist | 0.135 0.059 DBMET01310 | DBMET01310 | |
| 0.039 | 0.208 | 0.091 | Glycine receptor agonist | 0.091 0.027 DBMET01308 0.091 0.027 DBMET01309 0.081 0.037 DBMET01310 | DBMET01309 | |
| 0.05 | 0.222 | 0.137 | Cholinergic antagonist | 0.137 0.06 DBMET01310 | DBMET01310 | |
| 0.044 | 0.246 | 0.097 | AMP-activated protein kinase stimulant | 0.097 0.074 DBMET01308 | DBMET01308 | |
| 0.111 | 0.317 | 0.493 | Immunosuppressant | 0.313 0.107 DBMET00190 0.493 0.035 DBMET00191 0.313 0.107 DBMET00192 0.254 0.144 DBMET01308 0.475 0.04 DBMET01309 0.253 0.145 DBMET01310 | DBMET00191 | |
| 0.055 | 0.262 | 0.098 | Adenylate kinase inhibitor | 0.098 0.071 DBMET01308 0.098 0.071 DBMET01309 0.098 0.071 DBMET01310 | DBMET01310 | |
| 0.094 | 0.318 | 0.284 | Transcription factor NF kappa B inhibitor | 0.199 0.17 DBMET00190 0.221 0.15 DBMET00191 0.207 0.162 DBMET00192 0.272 0.112 DBMET01308 0.284 0.104 DBMET01309 0.264 0.117 DBMET01310 | DBMET01309 | |
| 0.041 | 0.274 | 0.1 | Thioredoxin inhibitor | 0.094 0.056 DBMET00190 0.1 0.049 DBMET01310 | DBMET01310 | |
| 0.065 | 0.313 | 0.128 | NOS3 expression enhancer | 0.125 0.106 DBMET00191 0.128 0.1 DBMET01309 | DBMET01309 | |
| 0.111 | 0.385 | 0.228 | Apoptosis antagonist | 0.228 0.149 DBMET00192 0.192 0.19 DBMET01308 | DBMET00192 | |
| 0.033 | 0.318 | 0.064 | MAP kinase kinase 8 inhibitor | 0.062 0.06 DBMET00191 0.064 0.055 DBMET01309 | DBMET01309 | |
| 0.048 | 0.35 | 0.134 | Farnesoid X receptor antagonist | 0.128 0.086 DBMET00192 0.134 0.076 DBMET01308 0.119 0.107 DBMET01309 | DBMET01308 | |
| 0.076 | 0.39 | 0.127 | MAP kinase kinase 4 inhibitor | 0.127 0.123 DBMET00191 0.127 0.123 DBMET00192 | DBMET00192 | |
| 0.008 | 0.323 | 0.075 | Antineoplastic antibiotic | 0.075 0.061 DBMET01310 | DBMET01310 | |
| 0.043 | 0.369 | 0.127 | Heat shock protein 90 antagonist | 0.127 0.102 DBMET01308 | DBMET01308 | |
| 0.025 | 0.353 | 0.086 | ATPase (Vacuolar H+) inhibitor | 0.081 0.076 DBMET00191 0.086 0.065 DBMET00192 0.086 0.064 DBMET01308 0.081 0.077 DBMET01309 | DBMET01308 | |
| 0.033 | 0.366 | 0.102 | Amylase inhibitor | 0.102 0.095 DBMET01308 0.102 0.095 DBMET01309 | DBMET01309 | |
| 0.043 | 0.376 | 0.156 | Immunostimulant | 0.156 0.15 DBMET01309 | DBMET01309 | |
| 0.052 | 0.421 | 0.18 | Hepatoprotectant | 0.159 0.1 DBMET00190 0.17 0.089 DBMET00191 0.132 0.13 DBMET00192 0.141 0.119 DBMET01308 0.18 0.079 DBMET01309 0.169 0.09 DBMET01310 | DBMET01309 | |
| 0.004 | 0.385 | 0.032 | Prostaglandin EP3 antagonist | 0.027 0.024 DBMET00191 0.032 0.019 DBMET01309 | DBMET01309 | |
| 0.074 | 0.466 | 0.256 | Antibacterial | 0.256 0.171 DBMET01309 0.254 0.173 DBMET01310 | DBMET01309 | |
| 0.051 | 0.496 | 0.121 | Growth hormone agonist | 0.121 0.12 DBMET01308 0.121 0.12 DBMET01309 0.121 0.12 DBMET01310 | DBMET01310 | |
| 0.005 | 0.467 | 0.147 | Prostaglandin EP2 antagonist | 0.123 0.014 DBMET00191 0.147 0.01 DBMET01309 | DBMET01309 | |
| 0.065 | 0.535 | 0.312 | Sodium/bile acid cotransporter inhibitor | 0.206 0.18 DBMET00190 0.276 0.102 DBMET00191 0.312 0.068 DBMET00192 0.306 0.074 DBMET01308 0.263 0.115 DBMET01309 | DBMET00192 | |
| 0.004 | 0.48 | 0.034 | Prostaglandin D2 agonist | 0.027 0.026 DBMET00191 0.034 0.017 DBMET01309 | DBMET01309 | |
| 0.033 | 0.518 | 0.133 | Nitric oxide antagonist | 0.133 0.114 DBMET01309 0.132 0.116 DBMET01310 | DBMET01309 | |
| 0.031 | 0.584 | 0.157 | Interleukin 4 antagonist | 0.138 0.062 DBMET00191 0.157 0.044 DBMET01309 | DBMET01309 | |
| 0.043 | 0.71 | 0.414 | Caspase 3 stimulant | 0.399 0.045 DBMET00190 0.239 0.123 DBMET00191 0.241 0.12 DBMET01309 0.414 0.04 DBMET01310 | DBMET01310 | |
| 0.011 | 0.763 | 0.171 | Vasodilator | 0.171 0.131 DBMET01309 | DBMET01309 | |
| 0.011 | 0.776 | 0.156 | Tumour necrosis factor alpha release inhibitor | 0.156 0.15 DBMET01310 | DBMET01310 | |
| 0.008 | 0.912 | 0.247 | Apoptosis agonist | 0.247 0.218 DBMET01310 | DBMET01310 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |